Patient Self-monitoring technology and devices

The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring is now performed in physician offices or similar healthcare settings. But this in changing. The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market by the end of the decade. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them to the patient in the proper context.

Publication Date: December 2009

Table of Contents

Executive Summary

Disease Management Market Dynamics

Patient Monitoring Overview

Self-Monitoring

Key Factors in Patient Compliance

Market Drivers

Shifting Patient Demographics

Industry Alignment and Competitive

Landscape

Self-Monitoring Technology Strategies

Needle-Stick Tests

Dry Chemistry Test Strips

Cassettes

Meters

Self-Collected / Mail-in Tests

Physician/Caregiver Testing

Rapid Response

CLIA Lab Testing

Meters

Single Mode Monitors

Combination Monitors

Future Developments

Noninvasive Monitors

Technologies

Optical

Energy-based

Thermal

Continuous Monitors

Technologies

Form Factors

Barriers and Risks

Measurement Electronics

Calibration

Accuracy/Precision

Sensitivity

Sensor Technology

Signal Processing Advances

Monitor Product Design & Patient Issues

Reliability

Measurement Frequency

Patient/User Interface

Ease-of-Use

Data Collection/Data Display

Continuous vs Discrete Monitoring

Self-Monitoring Therapeutic Segments

Atherosclerosis/Heart Disease (Cholesterol)

Measurement Modalities

Total Cholesterol

Triclycerides

Cholesterol Panel/Lipid Profile

Segment Demographics

Diabetes (Glucose)

Heart Valve Replacement/Thrombosis

Oral Anticoagulation Therapy

Prothrombin Time

Hypertension (Blood Pressure)

Oscillometric Measurements

Demographic Trends

Self-Monitoring Product Segment Analysis

Cholesterol Monitors

FDA Approved Products

Needle-stick

Spectrophotometric

Products in Development

Coagulation Monitoring

FDA Approved Products

Products in Development

Glucose Monitors

Traditional Meters

Needle-stick

Alternate Site Testing

Continuous Monitors

FDA-Approved Monitors

Development-stage Monitors

Noninvasive Glucose Monitors

Combination Monitors

FDA Approved Products

Products in Development

Hypertension

Existing Products

Emerging Technologies

Potential/Emerging Self-Monitoring Segments

Market Factors

Clinical Trial Issues

Patient Education

Managed care/Reimbursement

Patient Compliance

Marketing & Distribution

Sourcing/Private Labeling

Patient Self-Monitoring - Company Profiles

About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.